Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_assertion type Assertion NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_head.
- NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_assertion wasGeneratedBy ECO_0000203 NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_provenance.
- NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_assertion wasDerivedFrom befree-20140225 NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_provenance.
- NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_assertion SIO_000772 17961162 NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_provenance.
- NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_assertion evidence source_evidence_literature NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_provenance.
- NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_assertion description "[The staining intensity was gradually increased according to the severity of the dysplastic lesions; ERK2 immunoreactivity was significantly increased in high-grade dysplastic lesions (CIN II and CIN III) and invasive carcinomas by comparison to low-grade dysplastic lesions (CIN I) (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP188745.RA4YU4Y5rS3VBeSAprqfL2KfIjOLvKklGTmeWyaJ7zAZM130_provenance.